tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALKS Stock Latest News

Avadel Pharmaceuticals price target raised to $22.50 from $20 at Wells Fargo
The FlyAvadel Pharmaceuticals price target raised to $22.50 from $20 at Wells Fargo
4d ago
ALKS
AVDL
Cautious Optimism: Alkermes’ Strategic Moves and Market Potential Amidst Investor Concerns
PremiumRatings
Cautious Optimism: Alkermes’ Strategic Moves and Market Potential Amidst Investor Concerns
4d ago
ALKS
Alkermes Increases Offer for Avadel Acquisition
PremiumCompany Announcements
Alkermes Increases Offer for Avadel Acquisition
5d ago
8K
ALKS
Alkermes increases offer to acquire Avadel Pharmaceuticals to $22.50 per share
PremiumThe Fly
Alkermes increases offer to acquire Avadel Pharmaceuticals to $22.50 per share
5d ago
ALKS
AVDL
Centessa price target raised to $43 from $28 at Guggenheim
PremiumThe Fly
Centessa price target raised to $43 from $28 at Guggenheim
6d ago
ALKS
CNTA
Alkermes price target raised to $55 from $50 at Truist
PremiumThe FlyAlkermes price target raised to $55 from $50 at Truist
7d ago
ALKS
Avadel board declares Lundbeck proposal superior to Alkermes offer
Premium
The Fly
Avadel board declares Lundbeck proposal superior to Alkermes offer
7d ago
ALKS
AVDL
Truist thinks Alkermes can make counter offer acceptable to Avadel board
Premium
The Fly
Truist thinks Alkermes can make counter offer acceptable to Avadel board
10d ago
ALKS
AVDL
Alkermes falls -5.8%
PremiumThe Fly
Alkermes falls -5.8%
10d ago
ALKS
Alkermes falls -6.7%
PremiumThe Fly
Alkermes falls -6.7%
10d ago
ALKS
Alkermes issues response to Avadel announcement
PremiumThe Fly
Alkermes issues response to Avadel announcement
10d ago
ALKS
AVDL
Avadel receives $23 per share acquisition proposal from Lundbeck
PremiumThe Fly
Avadel receives $23 per share acquisition proposal from Lundbeck
10d ago
ALKS
AVDL
Alkermes price target lowered to $45 from $55 at Deutsche Bank
PremiumThe FlyAlkermes price target lowered to $45 from $55 at Deutsche Bank
11d ago
ALKS
Alkermes: Hold Rating Amid Mixed Trial Results and Uncertain Market Position
Premium
Ratings
Alkermes: Hold Rating Amid Mixed Trial Results and Uncertain Market Position
11d ago
ALKS
Morgan Stanley sees Centessa’s ORX750 as ‘best-in-class’ after competitor data
Premium
The Fly
Morgan Stanley sees Centessa’s ORX750 as ‘best-in-class’ after competitor data
12d ago
ALKS
CNTA
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
PremiumThe Fly
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
12d ago
C
T
Alkermes NT2 effect magnitude below ‘bullish expectations,’ says H.C. Wainwright
PremiumThe Fly
Alkermes NT2 effect magnitude below ‘bullish expectations,’ says H.C. Wainwright
12d ago
ALKS
Alkermes’ Strong Position and Misinterpreted Data: Justifying a Buy Rating
PremiumRatings
Alkermes’ Strong Position and Misinterpreted Data: Justifying a Buy Rating
12d ago
ALKS
Evercore disagrees with Street reaction on Alkermes
PremiumThe Fly
Evercore disagrees with Street reaction on Alkermes
12d ago
TAK
ALKS
Alkermes falls -10.7%
PremiumThe FlyAlkermes falls -10.7%
12d ago
ALKS
Alkermes Phase 2 narcolepsy study details ‘scant,’ says Truist
Premium
The Fly
Alkermes Phase 2 narcolepsy study details ‘scant,’ says Truist
12d ago
ALKS
Alkermes Announces Positive Results from Vibrance-2 Study
Premium
Company Announcements
Alkermes Announces Positive Results from Vibrance-2 Study
12d ago
8K
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >